Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib in Advanced Sarcomas
NCT00464620Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- May 2007
- Primary completion
- Dec 2016
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in sarcoma, gastrointestinal stromal tumor (GIST), sponsored by Sarcoma Alliance for Research through Collaboration. Started May 2007; status: completed.
02
Drugs
dasatinib
03
Conditions
sarcomagastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00464620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464620.